Jean-Charles Schwartz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Concepts & Ideas

Structure-Activity Relationship

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Isensee K; Amon M; Garlapati A; Ligneau X; Camelin J-C; Capet M; Schwartz J-C; Stark H
Fluorinated non-imidazole histamine H3 receptor antagonists.
Kuder K J; Ligneau X; Camelin J-C; Lazewska D; Schwartz J-C; Schunack W; Stark H; Kiec-Kononowicz K
Diether (substituted) piperidine derivatives as novel, histamine H3 receptor ligands.
Lazewska Dorota; Kuder Kamil; Ligneau Xavier; Schwartz Jean-Charles; Schunack Walter; Stark Holger; Kiec-Kononowicz Katarzyna
Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jean-Charles Schwartz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Isensee K; Amon M; Garlapati A; Ligneau X; Camelin J-C; Capet M; Schwartz J-C; Stark H
Fluorinated non-imidazole histamine H3 receptor antagonists.
Bioorganic & medicinal chemistry letters 2009;19(8):2172-5.
2009: Kuder K J; Ligneau X; Camelin J-C; Lazewska D; Schwartz J-C; Schunack W; Stark H; Kiec-Kononowicz K
Diether (substituted) piperidine derivatives as novel, histamine H3 receptor ligands.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2009;58 Suppl 1():47-8.
2008: Lazewska Dorota; Kuder Kamil; Ligneau Xavier; Schwartz Jean-Charles; Schunack Walter; Stark Holger; Kiec-Kononowicz Katarzyna
Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
Bioorganic & medicinal chemistry 2008;16(18):8729-36.
2008: Lin Jian-Sheng; Dauvilliers Yves; Arnulf Isabelle; Bastuji Hélène; Anaclet Christelle; Parmentier Régis; Kocher Laurence; Yanagisawa Masashi; Lehert Philippe; Ligneau Xavier; Perrin David; Robert Philippe; Roux Michel; Lecomte Jeanne-Marie; Schwartz Jean-Charles
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.
Neurobiology of disease 2008;30(1):74-83.
2007: Amon Michael; Ligneau Xavier; Camelin Jean-Claude; Berrebi-Bertrand Isabelle; Schwartz Jean-Charles; Stark Holger
Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands.
ChemMedChem 2007;2(5):708-16.
2007: Saur Oliver; Hackling Anneke E; Perachon Sylvie; Schwartz Jean-Charles; Sokoloff Pierre; Stark Holger
N-(4-(4-(2-Halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands.
Archiv der Pharmazie 2007;340(4):178-84.
2007: Ligneau Xavier; Landais Laurent; Perrin David; Piriou Johanne; Uguen Marilyne; Denis Emmanuel; Robert Philippe; Parmentier Régis; Anaclet Christelle; Lin Jian-Sheng; Burban Aude; Arrang Jean-Michel; Schwartz Jean-Charles
Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.
Biochemical pharmacology 2007;73(8):1215-24.
2007: Ligneau X; Perrin D; Landais L; Camelin J-C; Calmels T P G; Berrebi-Bertrand I; Lecomte J-M; Parmentier R; Anaclet C; Lin J-S; Bertaina-Anglade V; la Rochelle C Drieu; d'Aniello F; Rouleau A; Gbahou F; Arrang J-M; Ganellin C R; Stark H; Schunack W; Schwartz J-C
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology.
The Journal of pharmacology and experimental therapeutics 2007;320(1):365-75.
2006: Faucard Raphaël; Armand Vincent; Héron Anne; Cochois Véronique; Schwartz Jean-Charles; Arrang Jean-Michel
N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
Journal of neurochemistry 2006;98(5):1487-96.
2006: Lazewska Dorota; Ligneau Xavier; Schwartz Jean-Charles; Schunack Walter; Stark Holger; Kiec-Kononowicz Katarzyna
Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists.
Bioorganic & medicinal chemistry 2006;14(10):3522-9.
2006: Amon Michael; Ligneau Xavier; Schwartz Jean-Charles; Stark Holger
Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities.
Bioorganic & medicinal chemistry letters 2006;16(7):1938-40.
2005: Ganellin C Robin; Bishop Paul B; Bambal Ramesh B; Chan Suzanne M T; Leblond Bertrand; Moore Andrew N J; Zhao Lihua; Bourgeat Pierre; Rose Christiane; Vargas Froylan; Schwartz Jean-Charles
Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Journal of medicinal chemistry 2005;48(23):7333-42.
2005: Heidler Philipp; Zohrabi-Kalantari Vida; Calmels Thierry; Capet Marc; Berrebi-Bertrand Isabelle; Schwartz Jean-Charles; Stark Holger; Link Andreas
Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides.
Bioorganic & medicinal chemistry 2005;13(6):2009-14.
2005: Apelt J; Grassmann S; Ligneau X; Pertz H H; Ganellin C R; Arrang J M; Schwartz J C; Schunack W; Stark H
Search for histamine H3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives.
Die Pharmazie 2005;60(2):97-106.
2004: Grassmann Sven; Apelt Joachim; Ligneau Xavier; Pertz Heinz H; Arrang Jean-Michel; Ganellin C Robin; Schwartz Jean-Charles; Schunack Walter; Stark Holger
Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives.
Archiv der Pharmazie 2004;337(10):533-45.
2004: Rouleau Agnès; Héron Anne; Cochois Véronique; Pillot Catherine; Schwartz Jean-Charles; Arrang Jean-Michel
Cloning and expression of the mouse histamine H3 receptor: evidence for multiple isoforms.
Journal of neurochemistry 2004;90(6):1331-8.
2004: Pelloux-Léon Nadia; Fkyerat Abdellatif; Piripitsi Antonia; Tertiuk Wasyl; Schunack Walter; Stark Holger; Garbarg Monique; Ligneau Xavier; Arrang Jean-Michel; Schwartz Jean-Charles; Ganellin C Robin
Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.
Journal of medicinal chemistry 2004;47(12):3264-74.
2004: Meier Galina; Krause Michael; Hüls Annette; Ligneau Xavier; Pertz Heinz H; Arrang Jean-Michel; Ganellin C Robin; Schwartz Jean-Charles; Schunack Walter; Stark Holger
4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
Journal of medicinal chemistry 2004;47(10):2678-87.
2004: Mikó Tibor; Ligneau Xavier; Pertz Heinz H; Arrang Jean-Michel; Ganellin C Robin; Schwartz Jean-Charles; Schunack Walter; Stark Holger
Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
Bioorganic & medicinal chemistry 2004;12(10):2727-36.
2004: Mach Ulrich R; Hackling Anneke E; Perachon Sylvie; Ferry Sandrine; Wermuth Camille G; Schwartz Jean-Charles; Sokoloff Pierre; Stark Holger
Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands.
Chembiochem : a European journal of chemical biology 2004;5(4):508-18.
2004: Guillin Oliver; Griffon Nathalie; Diaz Jorge; Le Foll Bernard; Bezard Erwan; Gross Christian; Lammers Chris; Stark Holger; Carroll Patrick; Schwartz Jean-Charles; Sokoloff Pierre
Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway.
International review of neurobiology 2004;59():425-44.
2003: Gbahou Florence; Rouleau Agnès; Morisset Séverine; Parmentier Régis; Crochet Sylvain; Lin Jian-Sheng; Ligneau Xavier; Tardivel-Lacombe Joël; Stark Holger; Schunack Walter; Ganellin C Robin; Schwartz Jean-Charles; Arrang Jean-Michel
Protean agonism at histamine H3 receptors in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(19):11086-91.
2003: Hackling Anneke; Ghosh Robin; Perachon Sylvie; Mann André; Höltje Hans-Dieter; Wermuth Camille G; Schwartz Jean-Charles; Sippl Wolfgang; Sokoloff Pierre; Stark Holger
N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands.
Journal of medicinal chemistry 2003;46(18):3883-99.
2003: Leriche Ludovic; Schwartz Jean-Charles; Sokoloff Pierre
The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade.
Neuropharmacology 2003;45(2):174-81.
2003: Grassmann Sven; Apelt Joachim; Sippl Wolfgang; Ligneau Xavier; Pertz Heinz H; Zhao Yuan Hui; Arrang Jean Michel; Ganellin C Robin; Schwartz Jean Charles; Schunack Walter; Stark Holger
Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities.
Bioorganic & medicinal chemistry 2003;11(10):2163-74.
2003: Mikó Tibor; Ligneau Xavier; Pertz Heinz H; Ganellin C Robin; Arrang Jean-Michel; Schwartz Jean-Charles; Schunack Walter; Stark Holger
Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
Journal of medicinal chemistry 2003;46(8):1523-30.
2003: Le Foll B; Schwartz J-C; Sokoloff P
Disruption of nicotine conditioning by dopamine D(3) receptor ligands.
Molecular psychiatry 2003;8(2):225-30.
2003: Pillot Catherine; Héron Anne; Schwartz Jean-Charles; Arrang Jean-Michel
Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum.
The European journal of neuroscience 2003;17(2):307-14.
2003: Schwartz J C; Morisset S; Rouleau A; Ligneau X; Gbahou F; Tardivel-Lacombe J; Stark H; Schunack W; Ganellin C R; Arrang J M
Therapeutic implications of constitutive activity of receptors: the example of the histamine H3 receptor.
Journal of neural transmission. Supplementum 2003;(64):1-16.
2003: Facchinetti P; Rose C; Schwartz J C; Ouimet T
Ontogeny, regional and cellular distribution of the novel metalloprotease neprilysin 2 in the rat: a comparison with neprilysin and endothelin-converting enzyme-1.
Neuroscience 2003;118(3):627-39.
2002: Sasse Astrid; Ligneau Xavier; Rouleau Agnès; Elz Sigurd; Ganellin C Robin; Arrang Jean-Michel; Schwartz Jean-Charles; Schunack Walter; Stark Holger
Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.
Journal of medicinal chemistry 2002;45(18):4000-10.
2002: Pillot Catherine; Ortiz Jordi; Héron Anne; Ridray Sophie; Schwartz Jean-Charles; Arrang Jean-Michel
Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(16):7272-80.
2002: Meier Galina; Ligneau Xavier; Pertz Heinz H; Ganellin C Robin; Schwartz Jean-Charles; Schunack Walter; Stark Holger
Piperidino-hydrocarbon compounds as novel non-imidazole histamine H(3)-receptor antagonists.
Bioorganic & medicinal chemistry 2002;10(8):2535-42.
2002: Le Foll Bernard; Francès Henriette; Diaz Jorge; Schwartz Jean-Charles; Sokoloff Pierre
Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice.
The European journal of neuroscience 2002;15(12):2016-26.
2002: Trottier S; Chotard C; Traiffort E; Unmehopa U; Fisser B; Swaab D F; Schwartz J-C
Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus.
Brain research 2002;939(1-2):52-64.
2002: Grassmann Sven; Sadek Bassem; Ligneau Xavier; Elz Sigurd; Ganellin C Robin; Arrang Jean-Michel; Schwartz Jean-Charles; Stark Holger; Schunack Walter
Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2002;15(4):367-78.
2002: Rose Christiane; Voisin Stéphanie; Gros Claude; Schwartz Jean-Charles; Ouimet Tanja
Cell-specific activity of neprilysin 2 isoforms and enzymic specificity compared with neprilysin.
The Biochemical journal 2002;363(Pt 3):697-705.
2002: Wiecek M; Kiec-Kononowicz K; Sasse A; Ligneau X; Schwartz J C; Schunack W; Stark H
Impact of lipophilicity on the pharmacological properties of histamine H3-receptor antagonists of the cycloalkyl carbamate class.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2002;51 Suppl 1():S71-2.
2002: Chotard C; Ouimet T; Morisset S; Sahm U; Schwartz J C; Trottier S
Effects of histamine H3 receptor agonist and antagonist on histamine co-transmitter expression in rat brain.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(3):293-306.
2002: Apelt Joachim; Ligneau Xavier; Pertz Heinz H; Arrang Jean-Michel; Ganellin C Robin; Schwartz Jean-Charles; Schunack Walter; Stark Holger
Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.
Journal of medicinal chemistry 2002;45(5):1128-41.
2002: Morisset S; Pilon C; Tardivel-Lacombe J; Weinstein D; Rostene W; Betancur C; Sokoloff P; Schwartz J C; Arrang J M
Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.
The Journal of pharmacology and experimental therapeutics 2002;300(2):621-8.
2002: Rouleau A; Ligneau X; Tardivel-Lacombe J; Morisset S; Gbahou F; Schwartz J-C; Arrang J-M
Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.
British journal of pharmacology 2002;135(2):383-92.
2002: Pillot C; Heron A; Cochois V; Tardivel-Lacombe J; Ligneau X; Schwartz J-C; Arrang J-M
A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain.
Neuroscience 2002;114(1):173-93.
2001: Schwartz J C; Morisset S; Rouleau A; Tardivel-Lacombe J; Gbahou F; Ligneau X; Héron A; Sasse A; Stark H; Schunack W; Ganellin R C; Arrang J M
Application of genomics to drug design: the example of the histamine H3 receptor.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(6):441-8.
2001: Sokoloff P; Le Foll B; Perachon S; Bordet R; Ridray S; Schwartz J C
The dopamine D3 receptor and drug addiction.
Neurotoxicity research 2001;3(5):433-41.
2001: Héron A; Rouleau A; Cochois V; Pillot C; Schwartz J C; Arrang J M
Expression analysis of the histamine H(3) receptor in developing rat tissues.
Mechanisms of development 2001;105(1-2):167-73.
2001: Meier G; Apelt J; Reichert U; Grassmann S; Ligneau X; Elz S; Leurquin F; Ganellin C R; Schwartz J C; Schunack W; Stark H
Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;13(3):249-59.
2001: Guillin O; Diaz J; Carroll P; Griffon N; Schwartz J C; Sokoloff P
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.
Nature 2001;411(6833):86-9.
2001: Stark H; Sippl W; Ligneau X; Arrang J M; Ganellin C R; Schwartz J C; Schunack W
Different antagonist binding properties of human and rat histamine H3 receptors.
Bioorganic & medicinal chemistry letters 2001;11(7):951-4.
2001: Sasse A; Ligneau X; Sadek B; Elz S; Pertz H H; Ganellin C R; Arrang J M; Schwartz J C; Schunack W; Stark H
Benzophenone derivatives and related compounds as potent histamine H3-receptor antagonists and potential PET/SPECT ligands.
Archiv der Pharmazie 2001;334(2):45-52.
2001: Tardivel-Lacombe J; Morisset S; Gbahou F; Schwartz J C; Arrang J M
Chromosomal mapping and organization of the human histamine H3 receptor gene.
Neuroreport 2001;12(2):321-4.
2001: Stark H; Krause M; Rouleau A; Garbarg M; Schwartz J C; Schunack W
Enzyme-catalyzed prodrug approaches for the histamine H3-receptor agonist (R)-alpha-methylhistamine.
Bioorganic & medicinal chemistry 2001;9(1):191-8.
2001: Morisset S; Sasse A; Gbahou F; Héron A; Ligneau X; Tardivel-Lacombe J; Schwartz J C; Arrang J M
The rat H3 receptor: gene organization and multiple isoforms.
Biochemical and biophysical research communications 2001;280(1):75-80.
2001: Stark H; Arrang J M; Ligneau X; Garbarg M; Ganellin C R; Schwartz J C; Schunack W
The histamine H3 receptor and its ligands.
Progress in medicinal chemistry 2001;38():279-308.
2000: Morisset S; Rouleau A; Ligneau X; Gbahou F; Tardivel-Lacombe J; Stark H; Schunack W; Ganellin C R; Schwartz J C; Arrang J M
High constitutive activity of native H3 receptors regulates histamine neurons in brain.
Nature 2000;408(6814):860-4.
2000: Diaz J; Pilon C; Le Foll B; Gros C; Triller A; Schwartz J C; Sokoloff P
Dopamine D3 receptors expressed by all mesencephalic dopamine neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(23):8677-84.
2000: Ligneau X; Morisset S; Tardivel-Lacombe J; Gbahou F; Ganellin C R; Stark H; Schunack W; Schwartz J C; Arrang J M
Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain.
British journal of pharmacology 2000;131(7):1247-50.
2000: Stark H; Ligneau X; Sadek B; Ganellin C R; Arrang J M; Schwartz J C; Schunack W
Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.
Bioorganic & medicinal chemistry letters 2000;10(20):2379-82.
2000: Stark H; Sadek B; Krause M; Hüls A; Ligneau X; Ganellin C R; Arrang J M; Schwartz J C; Schunack W
Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.
Journal of medicinal chemistry 2000;43(21):3987-94.
2000: Drutel G; Kathmann M; Héron A; Gros C; Macé S; Schwartz J C; Arrang J M
Two splice variants of the hypoxia-inducible factor HIF-1alpha as potential dimerization partners of ARNT2 in neurons.
The European journal of neuroscience 2000;12(10):3701-8.
2000: Rouleau A; Stark H; Schunack W; Schwartz J C
Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H(3)-receptor agonist prodrug.
The Journal of pharmacology and experimental therapeutics 2000;295(1):219-25.
2000: Krebs M O; Guillin O; Bourdell M C; Schwartz J C; Olie J P; Poirier M F; Sokoloff P
Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia.
Molecular psychiatry 2000;5(5):558-62.
2000: Sasse A; Sadek B; Ligneau X; Elz S; Pertz H H; Luger P; Ganellin C R; Arrang J M; Schwartz J C; Schunack W; Stark H
New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.
Journal of medicinal chemistry 2000;43(17):3335-43.
2000: Lammers C H; Diaz J; Schwartz J C; Sokoloff P
Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
Molecular psychiatry 2000;5(4):378-88.
2000: Bordet R; Ridray S; Schwartz J C; Sokoloff P
Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
The European journal of neuroscience 2000;12(6):2117-23.
2000: Kiec-Kononowicz K; Wiecek M; Sasse A; Ligneau X; Elz S; Ganellin C R; Schwartz J C; Stark H; Schunack W
Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.
Die Pharmazie 2000;55(5):349-55.
2000: Lammers C H; Diaz J; Schwartz J C; Sokoloff P
Dopamine D3 receptor gene expression in the shell of nucleus accumbens is increased by chronic antidepressant treatment.
Molecular psychiatry 2000;5(3):229.
2000: Sasse A; Stark H; Ligneau X; Elz S; Reidemeister S; Ganellin C R; Schwartz J C; Schunack W
(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors.
Bioorganic & medicinal chemistry 2000;8(5):1139-49.
2000: Ouimet T; Facchinetti P; Rose C; Bonhomme M C; Gros C; Schwartz J C;
Neprilysin II: A putative novel metalloprotease and its isoforms in CNS and testis.
Biochemical and biophysical research communications 2000;271(3):565-70.
2000: Ito C; Morisset S; Krebs M O; Olié J P; Lôo H; Poirier M F; Lannfelt L; Schwartz J C; Arrang J M
Histamine H2 receptor gene variants: lack of association with schizophrenia.
Molecular psychiatry 2000;5(2):159-64.
2000: Tardivel-Lacombe J; Rouleau A; Héron A; Morisset S; Pillot C; Cochois V; Schwartz J C; Arrang J M
Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms.
Neuroreport 2000;11(4):755-9.
2000: Schwartz J C; Diaz J; Pilon C; Sokoloff P
Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions.
Brain research. Brain research reviews 2000;31(2-3):277-87.
2000: Reidemeister S; Stark H; Ligneau X; Ganellin C R; Schwartz J C; Schunack W
Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency.
Die Pharmazie 2000;55(2):83-6.
2000: Ganellin C R; Bishop P B; Bambal R B; Chan S M; Law J K; Marabout B; Luthra P M; Moore A N; Peschard O; Bourgeat P; Rose C; Vargas F; Schwartz J C
Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: a strategy for the design of peptidase inhibitors.
Journal of medicinal chemistry 2000;43(4):664-74.
2000: Perachon S; Betancur C; Pilon C; Rostène W; Schwartz J C; Sokoloff P
Role of dopamine D3 receptors in thermoregulation: a reappraisal.
Neuroreport 2000;11(1):221-5.
2000: Morisset S; Traiffort E; Arrang J M; Schwartz J C
Changes in histamine H3 receptor responsiveness in mouse brain.
Journal of neurochemistry 2000;74(1):339-46.
1999: Sasse A; Stark H; Reidemeister S; Hüls A; Elz S; Ligneau X; Ganellin C R; Schwartz J C; Schunack W
Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity.
Journal of medicinal chemistry 1999;42(20):4269-74.
1999: Pilla M; Perachon S; Sautel F; Garrido F; Mann A; Wermuth C G; Schwartz J C; Everitt B J; Sokoloff P
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist.
Nature 1999;400(6742):371-5.
1999: Drutel G; Héron A; Kathmann M; Gros C; Macé S; Plotkine M; Schwartz J C; Arrang J M
ARNT2, a transcription factor for brain neuron survival?
The European journal of neuroscience 1999;11(5):1545-53.
1999: Allard J; Barron S; Trottier S; Cervera P; Daumas-Duport C; Leguern E; Brice A; Schwartz J C; Sokoloff P
Edg-2 in myelin-forming cells: isoforms, genomic mapping, and exclusion in Charcot-Marie-Tooth disease.
Glia 1999;26(2):176-85.
1999: Perachon S; Schwartz J C; Sokoloff P
Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.
European journal of pharmacology 1999;366(2-3):293-300.
1999: Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin C R; Ligneau X; Schwartz J C; Schunack W
Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
Journal of medicinal chemistry 1999;42(4):593-600.
1999: Morisset S; Sahm U G; Traiffort E; Tardivel-Lacombe J; Arrang J M; Schwartz J C
Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade.
The Journal of pharmacology and experimental therapeutics 1999;288(2):590-6.
1999: Facchinetti P; Rose C; Rostaing P; Triller A; Schwartz J C
Immunolocalization of tripeptidyl peptidase II, a cholecystokinin-inactivating enzyme, in rat brain.
Neuroscience 1999;88(4):1225-40.
1998: Ganellin C R; Leurquin F; Piripitsi A; Arrang J M; Garbarg M; Ligneau X; Schunack W; Schwartz J C
Synthesis of potent non-imidazole histamine H3-receptor antagonists.
Archiv der Pharmazie 1998;331(12):395-404.
1998: Krause M; Ligneau X; Stark H; Garbarg M; Schwartz J C; Schunack W
4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
Journal of medicinal chemistry 1998;41(21):4171-6.
1998: Stark H; Ligneau X; Arrang J M; Schwartz J C; Schunack W
General construction pattern of histamine H3-receptor antagonists: change of a paradigm.
Bioorganic & medicinal chemistry letters 1998;8(15):2011-6.
1998: Krebs M O; Sautel F; Bourdel M C; Sokoloff P; Schwartz J C; Olié J P; Lôo H; Poirier M F
Dopamine D3 receptor gene variants and substance abuse in schizophrenia.
Molecular psychiatry 1998;3(4):337-41.
1998: Duaux E; Gorwood P; Griffon N; Bourdel M C; Sautel F; Sokoloff P; Schwartz J C; Ades J; Lôo H; Poirier M F
Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence.
Molecular psychiatry 1998;3(4):333-6.
1998: Dubertret C; Gorwood P; Ades J; Feingold J; Schwartz J C; Sokoloff P
Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians.
American journal of medical genetics 1998;81(4):318-22.
1998: Stark H; Hüls A; Ligneau X; Purand K; Pertz H; Arrang J M; Schwartz J C; Schunack W
Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
Archiv der Pharmazie 1998;331(6):211-8.
1998: Ridray S; Griffon N; Mignon V; Souil E; Carboni S; Diaz J; Schwartz J C; Sokoloff P
Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.
The European journal of neuroscience 1998;10(5):1676-86.
1998: Schwartz J C; Diaz J; Bordet R; Griffon N; Perachon S; Pilon C; Ridray S; Sokoloff P
Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence.
Brain research. Brain research reviews 1998;26(2-3):236-42.
1998: Allard J; Barrón S; Diaz J; Lubetzki C; Zalc B; Schwartz J C; Sokoloff P
A rat G protein-coupled receptor selectively expressed in myelin-forming cells.
The European journal of neuroscience 1998;10(3):1045-53.
1998: Sokoloff P; Diaz J; Bordet R; Griffon N; Perachon S; Pilon C; Ridray S; Schwartz J C
[Function and therapeutic potential of the dopamine D3 receptor]
Comptes rendus des séances de la Société de biologie et de ses filiales 1998;192(6):1111-25.
1998: Schwartz J C; Ridray S; Bordet R; Diaz J; Sokoloff P
D1/D3 receptor relationships in brain coexpression, coactivation, and coregulation.
Advances in pharmacology (San Diego, Calif.) 1998;42():408-11.
1997: Vizuete M L; Traiffort E; Bouthenet M L; Ruat M; Souil E; Tardivel-Lacombe J; Schwartz J C
Detailed mapping of the histamine H2 receptor and its gene transcripts in guinea-pig brain.
Neuroscience 1997;80(2):321-43.
1997: Stark H; Hüls A; Ligneau X; Arrang J M; Schwartz J C; Schunack W
Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives.
Die Pharmazie 1997;52(7):495-500.
1997: Stark H; Ligneau X; Lipp R; Arrang J M; Schwartz J C; Schunack W
Search for novel leads for histamine H3-receptor antagonists: amine derivatives.
Die Pharmazie 1997;52(6):419-23.
1997: Rouleau A; Garbarg M; Ligneau X; Mantion C; Lavie P; Advenier C; Lecomte J M; Krause M; Stark H; Schunack W; Schwartz J C
Bioavailability, antinociceptive and antiinflammatory properties of BP 2-94, a histamine H3 receptor agonist prodrug.
The Journal of pharmacology and experimental therapeutics 1997;281(3):1085-94.
1997: Diaz J; Ridray S; Mignon V; Griffon N; Schwartz J C; Sokoloff P
Selective expression of dopamine D3 receptor mRNA in proliferative zones during embryonic development of the rat brain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(11):4282-92.
1997: Bordet R; Ridray S; Carboni S; Diaz J; Sokoloff P; Schwartz J C
Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(7):3363-7.
1997: Dimitriadou V; Rouleau A; Trung Tuong M D; Newlands G J; Miller H R; Luffau G; Schwartz J C; Garbarg M
Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions.
Neuroscience 1997;77(3):829-39.
1997: Griffon N; Pilon C; Sautel F; Schwartz J C; Sokoloff P
Two intracellular signaling pathways for the dopamine D3 receptor: opposite and synergistic interactions with cyclic AMP.
Journal of neurochemistry 1997;68(1):1-9.
1997: Rouleau A; Dimitriadou V; Trung Tuong M D; Newlands G F; Miller H R; Schwartz J C; Garbarg M
Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(4-5):399-417.
1996: Morisset S; Traiffort E; Schwartz J C
Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity.
European journal of pharmacology 1996;315(1):R1-2.
1996: Dimitriadou V; Rouleau A; Tuong M D; Ligneau X; Newlands G F; Miller H R; Schwartz J C; Garbarg M
Rat cerebral mast cells undergo phenotypic changes during development.
Brain research. Developmental brain research 1996;97(1):29-41.
1996: Krause M; Rouleau A; Stark H; Garbarg M; Schwartz J C; Schunack W
Structure-activity relationships of novel azomethine prodrugs of the histamine H3-receptor agonist (R)-alpha-methylhistamine: from alkylaryl to substituted diaryl derivatives.
Die Pharmazie 1996;51(10):720-6.
1996: Buvry A; Garbarg M; Dimitriadou V; Rouleau A; Newlands G F; Tavakoli R; Poaty V; Lockhart A; Schwartz J C; Frossard N
Phenotypic and quantitative changes in mast cells after syngeneic unilateral lung transplantation in the rat.
Clinical science (London, England : 1979) 1996;91(3):319-27.
1996: Ganellin C R; Fkyerat A; Bang-Andersen B; Athmani S; Tertiuk W; Garbarg M; Ligneau X; Schwartz J C
A novel series of (phenoxyalkyl)imidazoles as potent H3-receptor histamine antagonists.
Journal of medicinal chemistry 1996;39(19):3806-13.
1996: Hüls A; Purand K; Stark H; Reidemeister S; Ligneau X; Arrang J M; Schwartz J C; Schunack W
Novel histamine H3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships.
Archiv der Pharmazie 1996;329(8-9):379-85.
1996: Héron A; Traiffort E; Allix M; Dimitriadou V; Schwartz J C
Prodynorphin mRNA expression in the rat dentate gyrus after cerebral ischemia.
Neuropeptides 1996;30(4):355-8.
1996: Drutel G; Kathmann M; Heron A; Schwartz J C; Arrang J M
Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator (ARNT).
Biochemical and biophysical research communications 1996;225(2):333-9.
1996: Krause M; Rouleau A; Stark H; Luger P; Garbarg M; Schwartz J C; Schunack W
New potent azomethine prodrugs of the histamine H3-receptor agonist (R)-alpha-methylhistamine containing a heteroarylphenyl partial structure.
Archiv der Pharmazie 1996;329(4):209-15.
1996: Rose C; Vargas F; Facchinetti P; Bourgeat P; Bambal R B; Bishop P B; Chan S M; Moore A N; Ganellin C R; Schwartz J C
Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
Nature 1996;380(6573):403-9.
1996: Stark H; Purand K; Ligneau X; Rouleau A; Arrang J M; Garbarg M; Schwartz J C; Schunack W
Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.
Journal of medicinal chemistry 1996;39(5):1157-63.
1996: Stark H; Purand K; Hüls A; Ligneau X; Garbarg M; Schwartz J C; Schunack W
[125I]iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor.
Journal of medicinal chemistry 1996;39(6):1220-6.
1996: Normant E; Schwartz J C; Gros C
A novel [125I]iodinated carboxypeptidase A substrate detects a metallopeptidase activity distinct from carboxypeptidase A in brain.
Neuropeptides 1996;30(1):13-7.
1996: Griffon N; Crocq M A; Pilon C; Martres M P; Mayerova A; Uyanik G; Burgert E; Duval F; Macher J P; Javoy-Agid F; Tamminga C A; Schwartz J C; Sokoloff P
Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia.
American journal of medical genetics 1996;67(1):63-70.
1996: Griffon N; Sautel F; Pilon C; Lévesque D; Sokoloff P; Schwartz J C; Diaz J; Simon P; Costentin J; Mann A; Wermuth C G
Functional models for the dopamine D3 receptor.
Biochemical Society transactions 1996;24(1):193-8.
1996: Griffon N; Pilon C; Sautel F; Schwartz J C; Sokoloff P
Antipsychotics with inverse agonist activity at the dopamine D3 receptor.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(10):1163-75.
1995: Normant E; Martres M P; Schwartz J C; Gros C
Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(26):12225-9.
1995: Sautel F; Griffon N; Sokoloff P; Schwartz J C; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
The Journal of pharmacology and experimental therapeutics 1995;275(3):1239-46.
1995: Schwartz J C; Griffon N; Diaz J; Levesque D; Sautel F; Sokoloff P; Simon P; Costentin J; Garrido F; Mann A
The D3 receptor and its relevance in psychiatry.
International clinical psychopharmacology 1995;10 Suppl 3():15-20.
1995: Normant E; Gros C; Schwartz J C
Carboxypeptidase A isoforms produced by distinct genes or alternative splicing in brain and other extrapancreatic tissues.
The Journal of biological chemistry 1995;270(35):20543-9.
1995: Ganellin C R; Hosseini S K; Khalaf Y S; Tertiuk W; Arrang J M; Garbarg M; Ligneau X; Schwartz J C
Design of potent non-thiourea H3-receptor histamine antagonists.
Journal of medicinal chemistry 1995;38(17):3342-50.
1995: Griffon N; Pilon C; Schwartz J C; Sokoloff P
The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist.
European journal of pharmacology 1995;282(1-3):R3-4.
1995: Sokoloff P; Schwartz J C
Novel dopamine receptors half a decade later.
Trends in pharmacological sciences 1995;16(8):270-5.
1995: Traiffort E; Vizuete M L; Tardivel-Lacombe J; Souil E; Schwartz J C; Ruat M
The guinea pig histamine H2 receptor: gene cloning, tissue expression and chromosomal localization of its human counterpart.
Biochemical and biophysical research communications 1995;211(2):570-7.
1995: Vizuete M L; Dimitriadou V; Traiffort E; Griffon N; Heron A; Schwartz J C
Endogenous histamine induces c-fos expression within paraventricular and supraoptic nuclei.
Neuroreport 1995;6(7):1041-4.
1995: Kiec-Kononowicz K; Ligneau X; Schwartz J C; Schunack W
Pyrazoles as potential histamine H3-receptor antagonists.
Archiv der Pharmazie 1995;328(5):469-72.
1995: Kiec-Kononowicz K; Ligneau X; Stark H; Schwartz J C; Schunack W
Azines and diazines as potential histamine H3-receptor antagonists.
Archiv der Pharmazie 1995;328(5):445-50.
1995: Arrang J M; Drutel G; Garbarg M; Ruat M; Traiffort E; Schwartz J C
Molecular and functional diversity of histamine receptor subtypes.
Annals of the New York Academy of Sciences 1995;757():314-23.
1995: Sokoloff P; Diaz J; Levesque D; Pilon C; Dimitriadou V; Griffon N; Lammers C H; Martres M P; Schwartz J C
Novel dopamine receptor subtypes as targets for antipsychotic drugs.
Annals of the New York Academy of Sciences 1995;757():278-92.
1995: Diaz J; Lévesque D; Lammers C H; Griffon N; Martres M P; Schwartz J C; Sokoloff P
Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.
Neuroscience 1995;65(3):731-45.
1995: Arrang J M; Drutel G; Schwartz J C
Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex.
British journal of pharmacology 1995;114(7):1518-22.
1995: Rose C; Vargas F; Silhouette B; Devaux B; Schwartz J C
Characterization of a serine peptidase responsible for the inactivation of endogenous cholecystokinin in human brain.
Neuropeptides 1995;28(3):157-60.
1995: Ganellin C R; Fkyerat A; Hosseini S K; Khalaf Y S; Piripitsi A; Tertiuk W; Arrang J M; Garbarg M; Ligneau X; Schwartz J C
Structure-activity studies with histamine H3-receptor ligands.
Journal de pharmacie de Belgique 1995;50(2-3):179-87.
1995: Lévesque D; Martres M P; Diaz J; Griffon N; Lammers C H; Sokoloff P; Schwartz J C
A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(5):1719-23.
1995: Sautel F; Griffon N; Lévesque D; Pilon C; Schwartz J C; Sokoloff P
A functional test identifies dopamine agonists selective for D3 versus D2 receptors.
Neuroreport 1995;6(2):329-32.
1995: Griffon N; Sokoloff P; Diaz J; Lévesque D; Sautel F; Schwartz J C; Simon P; Costentin J; Garrido F; Mann A
The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5 Suppl():3-9.
1995: Drutel G; Arrang J M; Diaz J; Wisnewsky C; Schwartz K; Schwartz J C
Cloning of OL1, a putative olfactory receptor and its expression in the developing rat heart.
Receptors & channels 1995;3(1):33-40.
1994: Di Marzo V; Fontana A; Cadas H; Schinelli S; Cimino G; Schwartz J C; Piomelli D
Formation and inactivation of endogenous cannabinoid anandamide in central neurons.
Nature 1994;372(6507):686-91.
1994: Ligneau X; Garbarg M; Vizuete M L; Diaz J; Purand K; Stark H; Schunack W; Schwartz J C
[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.
The Journal of pharmacology and experimental therapeutics 1994;271(1):452-9.
1994: Diaz J; Lévesque D; Griffon N; Lammers C H; Martres M P; Sokoloff P; Schwartz J C
Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens.
The European journal of neuroscience 1994;6(8):1384-7.
1994: Dimitriadou V; Rouleau A; Dam Trung Tuong M; Newlands G J; Miller H R; Luffau G; Schwartz J C; Garbarg M
Functional relationship between mast cells and C-sensitive nerve fibres evidenced by histamine H3-receptor modulation in rat lung and spleen.
Clinical science (London, England : 1979) 1994;87(2):151-63.
1994: Rouleau A; Tuong M D; Newlands G F; Miller H R; Schwartz J C; Garbarg M
Fasting or dexamethasone treatment reduce protease content in rat lung mast cells and modulation of histamine synthesis by H3 receptors.
Agents and actions 1994;42(1-2):7-12.
1994: Pilon C; Lévesque D; Dimitriadou V; Griffon N; Martres M P; Schwartz J C; Sokoloff P
Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line.
European journal of pharmacology 1994;268(2):129-39.
1994: Griffon N; Mignon V; Facchinetti P; Diaz J; Schwartz J C; Sokoloff P
Molecular cloning and characterization of the rat fifth melanocortin receptor.
Biochemical and biophysical research communications 1994;200(2):1007-14.
1994: Rouleau A; Garbarg M; Schwartz J C; Ruat M
Molecular cloning of rat mast cell protease 1 and development of specific probes for its gene transcript.
Biochemical and biophysical research communications 1994;199(2):593-602.
1994: Leurs R; Traiffort E; Arrang J M; Tardivel-Lacombe J; Ruat M; Schwartz J C
Guinea pig histamine H1 receptor. II. Stable expression in Chinese hamster ovary cells reveals the interaction with three major signal transduction pathways.
Journal of neurochemistry 1994;62(2):519-27.
1994: Traiffort E; Leurs R; Arrang J M; Tardivel-Lacombe J; Diaz J; Schwartz J C; Ruat M
Guinea pig histamine H1 receptor. I. Gene cloning, characterization, and tissue expression revealed by in situ hybridization.
Journal of neurochemistry 1994;62(2):507-18.
1994: Diaz J; Vizuete M L; Traiffort E; Arrang J M; Ruat M; Schwartz J C
Localization of the histamine H2 receptor and gene transcripts in rat stomach: back to parietal cells.
Biochemical and biophysical research communications 1994;198(3):1195-202.
1994: Gros C; Schwartz J C; Duhamel P L; Lecomte J M; Bralet J
"Atriopeptidase" (EC 3.4.24.11) inhibition and protection of atrial natriuretic factor.
Advances in nephrology from the Necker Hospital 1994;23():233-46.
1994: Schwartz J C; Diaz J; Griffon N; Levesque D; Martres M P; Sokoloff P
Multiple dopamine receptors: the D3 receptor and actions of substances of abuse.
EXS 1994;71():81-92.
1993: Ruat M; Traiffort E; Leurs R; Tardivel-Lacombe J; Diaz J; Arrang J M; Schwartz J C
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(18):8547-51.
1993: Schwartz J C; Levesque D; Martres M P; Sokoloff P
Dopamine D3 receptor: basic and clinical aspects.
Clinical neuropharmacology 1993;16(4):295-314.
1993: Ruat M; Traiffort E; Arrang J M; Tardivel-Lacombe J; Diaz J; Leurs R; Schwartz J C
A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.
Biochemical and biophysical research communications 1993;193(1):268-76.
1993: Pollard H; Moreau J; Arrang J M; Schwartz J C
A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas.
Neuroscience 1993;52(1):169-89.
1993: Garbarg M; Schwartz J C
The histamine H3 receptor: pharmacology and potential therapeutic applications.
Annales françaises d'anesthèsie et de rèanimation 1993;12(2):114-5.
1993: Giros B; Sokoloff P; Martres M P; Lannfelt L; Andrieux M; Besançon R; Pilon C; Bouthenet M L; Souil E; Schwartz J C
The third dopamine receptor (D3): new perspectives in therapeutics.
Psychopharmacology series 1993;10():82-93.
1992: Crocq M A; Mant R; Asherson P; Williams J; Hode Y; Mayerova A; Collier D; Lannfelt L; Sokoloff P; Schwartz J C
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene.
Journal of medical genetics 1992;29(12):858-60.
1992: Lipp R; Arrang J M; Garbarg M; Luger P; Schwartz J C; Schunack W
Synthesis, absolute configuration, stereoselectivity, and receptor selectivity of (alpha R, beta S)-alpha,beta-dimethylhistamine, a novel high potent histamine H3 receptor agonist.
Journal of medicinal chemistry 1992;35(23):4434-41.
1992: Garbarg M; Arrang J M; Rouleau A; Ligneau X; Tuong M D; Schwartz J C; Ganellin C R
S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
The Journal of pharmacology and experimental therapeutics 1992;263(1):304-10.
1992: Lévesque D; Diaz J; Pilon C; Martres M P; Giros B; Souil E; Schott D; Morgat J L; Schwartz J C; Sokoloff P
Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(17):8155-9.
1992: Traiffort E; Pollard H; Moreau J; Ruat M; Schwartz J C; Martinez-Mir M I; Palacios J M
Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidine.
Journal of neurochemistry 1992;59(1):290-9.
1992: Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz J C
Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
Journal of medicinal chemistry 1992;35(12):2231-8.
1992: Sokoloff P; Andrieux M; Besançon R; Pilon C; Martres M P; Giros B; Schwartz J C
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.
European journal of pharmacology 1992;225(4):331-7.
1992: Traiffort E; Ruat M; Arrang J M; Leurs R; Piomelli D; Schwartz J C
Expression of a cloned rat histamine H2 receptor mediating inhibition of arachidonate release and activation of cAMP accumulation.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(7):2649-53.
1992: Souque A; Gros C; Schwartz J C
Binding of [125I]atrial natriuretic factor to mouse lung membranes in vivo: characterization and effects of peptidase inhibitors.
The Journal of pharmacology and experimental therapeutics 1992;260(3):1373-8.
1992: Sokoloff P; Martres M P; Giros B; Bouthenet M L; Schwartz J C
Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology.
Neurochemistry international 1992;20 Suppl():27S-32S.
1992: Sokoloff P; Giros B; Martres M P; Andrieux M; Besancon R; Pilon C; Bouthenet M L; Souil E; Schwartz J C
Localization and function of the D3 dopamine receptor.
Arzneimittel-Forschung 1992;42(2A):224-30.
1992: Martres M P; Sokoloff P; Giros B; Bouthenet M L; Pilon C; Lannfelt L; Schwartz J C
[Dopaminergic receptors, multiple targets for neuroleptics]
Annales médico-psychologiques 1992;150(2-3):119-23.
1992: Sokoloff P; Martres M P; Giros B; Bouthenet M L; Schwartz J C
The third dopamine receptor (D3) as a novel target for antipsychotics.
Biochemical pharmacology 1992;43(4):659-66.
1992: Martres M P; Sokoloff P; Giros B; Schwartz J C
Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues.
Journal of neurochemistry 1992;58(2):673-9.
1992: Ruat M; Traiffort E; Garbarg M; Schwartz J C; Demonchaux P; Ife R J; Tertiuk W; Ganellin C R
Design of an affinity matrix for purification of the histamine H1 receptor from guinea pig cerebellum.
Journal of neurochemistry 1992;58(1):350-6.
1992: Ruat M; Traiffort E; Leurs R; Arrang J M; Kouyoumdjian G; Tardivel-Lacombe J; Piomelli D; Diaz G; Schwartz J C
Molecular biology and pharmacology of histamine receptor subtypes.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():149A-150A.
1992: Schwartz J C
Multiple dopamine receptors: functional implications.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():1A-2A.
1992: Sokoloff P; Levesque D; Martres M P; Lannfelt L; Diaz G; Pilon C; Schwartz J C
The dopamine D3 receptor as a key target for antipsychotics.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():456A-457A.
1991: Bouthenet M L; Souil E; Martres M P; Sokoloff P; Giros B; Schwartz J C
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.
Brain research 1991;564(2):203-19.
1991: Ruat M; Traiffort E; Arrang J M; Leurs R; Schwartz J C
Cloning and tissue expression of a rat histamine H2-receptor gene.
Biochemical and biophysical research communications 1991;179(3):1470-8.
1991: Piomelli D; Pilon C; Giros B; Sokoloff P; Martres M P; Schwartz J C
Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism.
Nature 1991;353(6340):164-7.
1991: Arrang J M; Gulat-Marnay C; Defontaine N; Schwartz J C
Regulation of histamine release in rat hypothalamus and hippocampus by presynaptic galanin receptors.
Peptides 1991;12(5):1113-7.
1991: Traiffort E; Ruat M; Schwartz J C
Interaction of mianserin, amitriptyline and haloperidol with guinea pig cerebral histamine H2 receptors studied with [125I]iodoaminopotentidine.
European journal of pharmacology 1991;207(2):143-8.
1991: Hartmann F; Poirier M F; Bourdel M C; Loo H; Lecomte J M; Schwartz J C
Comparison of acetorphan with clonidine for opiate withdrawal symptoms.
The American journal of psychiatry 1991;148(5):627-9.
1991: Gros C; Noël N; Souque A; Schwartz J C; Danvy D; Plaquevent J C; Duhamel L; Duhamel P; Lecomte J M; Bralet J
Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(10):4210-4.
1991: Llorens-Cortes C; Zini S; Gros C; Schwartz J C
Dopaminergic regulation of enkephalin release.
Journal of neurochemistry 1991;56(4):1368-75.
1991: Lipp R; Arrang J M; Buschmann J; Garbarg M; Luger P; Schunack W; Schwartz J C
Novel chiral H3-receptor agonists.
Agents and actions. Supplements 1991;33():277-82.
1991: Ruat M; Traiffort E; Bouthenet M L; Souil E; Pollard H; Moreau J; Schwartz J C; Martinez-Mir I; Palacios J M; Hirschfeld J
Reversible and irreversible labelling of H1- and H2 -receptors using novel [125I] probes.
Agents and actions. Supplements 1991;33():123-44.
1991: Arrang J M; Garbarg M; Schwartz J C; Lipp R; Stark H; Schunack W; Lecomte J M
The histamine H3-receptor: pharmacology, roles and clinical implications studied with agonists.
Agents and actions. Supplements 1991;33():55-67.
1990: Llorens-Cortes C; Giros B; Schwartz J C
A novel potential metallopeptidase derived from the enkephalinase gene by alternative splicing.
Journal of neurochemistry 1990;55(6):2146-8.
1990: Gros C; Souque A; Schwartz J C
Degradation of atrial natriuretic factor in mouse blood in vitro and in vivo: role of enkephalinase (EC 3.4.24.11).
Neuropeptides 1990;17(1):1-5.
1990: Martinez-Mir M I; Pollard H; Moreau J; Arrang J M; Ruat M; Traiffort E; Schwartz J C; Palacios J M
Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates.
Brain research 1990;526(2):322-7.
1990: Sokoloff P; Giros B; Martres M P; Bouthenet M L; Schwartz J C
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
Nature 1990;347(6289):146-51.
1990: Ruat M; Bouthenet M L; Schwartz J C; Ganellin C R
Histamine H1-receptor in heart: unique electrophoretic mobility and autoradiographic localization.
Journal of neurochemistry 1990;55(2):379-85.
1990: Llorens-Cortes C; Van Amsterdam J G; Giros B; Quach T T; Schwartz J C
Enkephalin biosynthesis and release in mouse striatum are inhibited by GABA receptor stimulation: compared changes in preproenkephalin mRNA and Tyr-Gly-Gly levels.
Brain research. Molecular brain research 1990;8(3):227-33.
1990: Gulat-Marnay C; Lafitte A; Arrang J M; Schwartz J C
Modulation of histamine release in the rat brain by kappa-opioid receptors.
Journal of neurochemistry 1990;55(1):47-53.
1990: Gros C; Souque A; Schwartz J C
Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11).
European journal of pharmacology 1990;179(1-2):45-56.
1990: Schwartz J C; Arrang J M; Garbarg M; Pollard H
Plenary lecture. A third histamine receptor subtype: characterisation, localisation and functions of the H3-receptor.
Agents and actions 1990;30(1-2):13-23.
1990: Arrang J M; Roy J; Morgat J L; Schunack W; Schwartz J C
Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations.
European journal of pharmacology 1990;188(4-5):219-27.
1990: Ruat M; Traiffort E; Bouthenet M L; Schwartz J C; Hirschfeld J; Buschauer A; Schunack W
Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(5):1658-62.
1990: Llorens-Cortes C; Giros B; Quach T T; Schwartz J C
Adaptative changes in two indices of enkephalin neuron activity in mouse striatum following GABAergic stimulation.
Progress in clinical and biological research 1990;328():203-6.
1990: Schwartz J C; Gros C; Lecomte J M; Bralet J
Enkephalinase (EC 3.4.24.11) inhibitors: protection of endogenous ANF against inactivation and potential therapeutic applications.
Life sciences 1990;47(15):1279-97.
1990: Schwartz J C; Arrang J M; Garbarg M; Gulat-Marnay C; Pollard H
Modulation of histamine synthesis and release in brain via presynaptic autoreceptors and heteroreceptors.
Annals of the New York Academy of Sciences 1990;604():40-54.
1989: Garbarg M; Pollard H; Trung Tuong M D; Schwartz J C; Gros C
Sensitive radioimmunoassays for histamine and tele-methylhistamine in the brain.
Journal of neurochemistry 1989;53(6):1724-30.
1989: Giros B; Sokoloff P; Martres M P; Riou J F; Emorine L J; Schwartz J C
Alternative splicing directs the expression of two D2 dopamine receptor isoforms.
Nature 1989;342(6252):923-6.
1989: Gros C; Souque A; Schwartz J C; Duchier J; Cournot A; Baumer P; Lecomte J M
Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(19):7580-4.
1989: Ruat M; Schwartz J C
Photoaffinity labeling and electrophoretic identification of the H1-receptor: comparison of several brain regions and animal species.
Journal of neurochemistry 1989;53(2):335-9.
1989: Gulat-Marnay C; Lafitte A; Arrang J M; Schwartz J C
Modulation of histamine release and synthesis in the brain mediated by alpha 2-adrenoceptors.
Journal of neurochemistry 1989;53(2):513-8.
1989: Sokoloff P; Riou J F; Martres M P; Schwartz J C
Presence of dopamine D-2 receptors in human tumoral cell lines.
Biochemical and biophysical research communications 1989;162(2):575-82.
1989: Garbarg M; Tuong M D; Gros C; Schwartz J C
Effects of histamine H3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain.
European journal of pharmacology 1989;164(1):1-11.
1989: Llorens-Cortes C; Martres M P; Van Amsterdam Y; Giros B; Gros C; Pollard H; Schwartz J C
[Dopamine and enkephalins. Effects of dopaminergic agents on the levels of striatal tyrosyl-glycyl-glycine]
L'Encéphale 1989;15 Spec No():105-9.
1989: Gulat-Marnay C; Lafitte A; Arrang J M; Schwartz J C
Regulation of histamine release and synthesis in the brain by muscarinic receptors.
Journal of neurochemistry 1989;52(1):248-54.
1989: Rose C; Camus A; Schwartz J C
Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices.
Neuroscience 1989;29(3):583-94.
1989: Arrang J M; Garbarg M; Lancelot J C; Lecomte J M; Pollard H; Robba M; Schunack W; Schwartz J C
The third histamine receptor. Highly potent and selective ligands.
International archives of allergy and applied immunology 1989;88(1-2):79-81.
1989: Schwartz J C; Arrang J M; Garbarg M; Pollard H
Histamine H3 receptors in the brain: potent and selective ligands.
Psychopharmacology series 1989;7():10-9.
1989: Camus A; Rose C; Schwartz J C
Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slices.
Neuroscience 1989;29(3):595-602.
1989: Sales N; Martres M P; Bouthenet M L; Schwartz J C
Ontogeny of dopaminergic D-2 receptors in the rat nervous system: characterization and detailed autoradiographic mapping with [125I]iodosulpride.
Neuroscience 1989;28(3):673-700.
1989: Pollard H; Bouthenet M L; Moreau J; Souil E; Verroust P; Ronco P; Schwartz J C
Detailed immunoautoradiographic mapping of enkephalinase (EC 3.4.24.11) in rat central nervous system: comparison with enkephalins and substance P.
Neuroscience 1989;30(2):339-76.
1988: De la Baume S; Brion F; Dam Trung Tuong M; Schwartz J C
Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
The Journal of pharmacology and experimental therapeutics 1988;247(2):653-60.
1988: Arrang J M; Defontaine N; Schwartz J C
Phencyclidine blocks histamine H3-receptors in rat brain.
European journal of pharmacology 1988;157(1):31-5.
1988: Arrang J M; Garbarg M; Lancelot J C; Lecomte J M; Pollard H; Robba M; Schunack W; Schwartz J C
[Potential interest in powerful and specific ligands for the histamine H3 receptor]
Allergie et immunologie 1988;20(9):327-9, 331.
1988: Gros C; Giros B; Schwartz J C; Vlaiculescu A; Costentin J; Lecomte J M
Potent inhibition of cerebral aminopeptidases by carbaphethiol, a parenterally active compound.
Neuropeptides 1988;12(3):111-8.
1988: Arrang J M; Garbarg M; Lancelot J C; Lecomte J M; Pollard H; Robba M; Schunack W; Schwartz J C
Highly potent and selective ligands for a new class H3 of histamine receptor.
Investigative radiology 1988;23 Suppl 1():S130-2.
1988: Bouthenet M L; Ruat M; Sales N; Garbarg M; Schwartz J C
A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine.
Neuroscience 1988;26(2):553-600.
1988: Arrang J M; Devaux B; Chodkiewicz J P; Schwartz J C
H3-receptors control histamine release in human brain.
Journal of neurochemistry 1988;51(1):105-8.
1988: Ruat M; Körner M; Garbarg M; Gros C; Schwartz J C; Tertiuk W; Ganellin C R
Characterization of histamine H1-receptor binding peptides in guinea pig brain using [125I]iodoazidophenpyramine, an irreversible specific photoaffinity probe.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(8):2743-7.
1988: De la Baume S; Schwartz J C
Labelling and exploration of the active site of enkephalinase (EC 3.4.24.11) in kidney membranes with [3H]thiorphan as ligand.
European journal of pharmacology 1988;149(1-2):121-9.
1988: Garbarg M; Schwartz J C
Synergism between histamine H1- and H2-receptors in the cAMP response in guinea pig brain slices: effects of phorbol esters and calcium.
Molecular pharmacology 1988;33(1):38-43.
1987: Giros B; Gros C; Schwartz J C; Danvy D; Plaquevent J C; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte J M
Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
The Journal of pharmacology and experimental therapeutics 1987;243(2):666-73.
1987: Gulat-Marnay C; Lafitte A; Vargas F; Schwartz J C
Formation and utilization of the active sulfate donor [35S]3'-phosphoadenosine 5'-phosphosulfate in brain slices: effects of depolarizing agents.
Journal of neurochemistry 1987;49(5):1443-8.
1987: Arrang J M; Garbarg M; Schwartz J C
Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors.
Neuroscience 1987;23(1):149-57.
1987: Solhonne B; Gros C; Pollard H; Schwartz J C
Major localization of aminopeptidase M in rat brain microvessels.
Neuroscience 1987;22(1):225-32.
1987: Bouthenet M L; Martres M P; Sales N; Schwartz J C
A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride.
Neuroscience 1987;20(1):117-55.
1986: Schwartz J C; Arrang J M; Garbarg M; Korner M
Properties and roles of the three subclasses of histamine receptors in brain.
The Journal of experimental biology 1986;124():203-24.
1986: Lecomte J M; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz J C
Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
The Journal of pharmacology and experimental therapeutics 1986;237(3):937-44.
1986: Costentin J; Vlaiculescu A; Chaillet P; Ben Natan L; Aveaux D; Schwartz J C
Dissociated effects of inhibitors of enkephalin-metabolising peptidases or naloxone on various nociceptive responses.
European journal of pharmacology 1986;123(1):37-44.
1986: Giros B; Gros C; Solhonne B; Schwartz J C
Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
Molecular pharmacology 1986;29(3):281-7.
1986: Korner M; Bouthenet M L; Ganellin C R; Garbarg M; Gros C; Ife R J; Sales N; Schwartz J C
[125I]Iodobolpyramine, a highly sensitive probe for histamine H1-receptors in guinea-pig brain.
European journal of pharmacology 1986;120(2):151-60.
1986: Schwartz J C; de la Baume S; Bouthenet M L; Giros B; Gros C; Llorens-Cortes C; Pollard H; Sales N; Solhonne B; Costentin J
[Neuropeptidases responsible for the inactivation of enkephalins and the pharmacology of their inhibitors]
Journal de pharmacologie 1986;17 Suppl 2():104-22.
1986: Vargas F; Tuong M D; Schwartz J C
Inhibitors and dipeptide substrates for a microsomal tyrosylsulfotransferase from rat brain.
Journal of enzyme inhibition 1986;1(2):105-12.
1986: Llorens-Cortes C; Gros C; Schwartz J C
Evaluation of striatal enkephalin release in vivo from steady state levels and turnover rates of the tripeptide Tyr-Gly-Gly.
NIDA research monograph 1986;75():275-8.
1986: Gros C; Solhonne B; Giros B; Pollard H; Salès N; Schwartz J C; Ronco P; Verroust P
Immunohistochemical and subcellular studies of aminopeptidase M localization in rat brain: microvessels and synaptic membranes.
NIDA research monograph 1986;75():303-6.
1985: Martres M P; Sales N; Bouthenet M L; Schwartz J C
Localisation and pharmacological characterisation of D-2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I]iodosulpride.
European journal of pharmacology 1985;118(3):211-9.
1985: Redouane K; Sokoloff P; Schwartz J C; Hamdi P; Mann A; Wermuth C G; Roy J; Morgat J L
Photoaffinity labeling of D-2 dopamine binding subunits from rat striatum, anterior pituitary and olfactory bulb with a new probe, [3H]azidosulpride.
Biochemical and biophysical research communications 1985;130(3):1086-92.
1985: Bouthenet M L; Sales N; Schwartz J C
Autoradiographic localisation of 3H-apomorphine binding sites in rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1985;330(1):1-8.
1985: Sokoloff P; Redouane K; Brann M; Martres M P; Schwartz J C
3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites.
Naunyn-Schmiedeberg's archives of pharmacology 1985;329(3):236-43.
1985: Martres M P; Bouthenet M L; Sales N; Sokoloff P; Schwartz J C
Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand.
Science (New York, N.Y.) 1985;228(4700):752-5.
1985: Gulat-Marnay C; Lafitte A; Schwartz J C; Protais P
Effects of discriminant and non-discriminant dopamine antagonists on in vivo accumulation of 3H-N-propyl-norapomorphine in mouse striatum and tuberculum olfactorium.
Naunyn-Schmiedeberg's archives of pharmacology 1985;329(2):117-22.
1985: Sokoloff P; Brann M; Redouane K; Martres M P; Schwartz J C; Bouthenet M L; Sales N; Mann A; Hamdi P; Wermuth C G
The use of [3H](-)-DO 710 as selective dopaminergic ligand for binding and autoradiographic studies.
European journal of pharmacology 1985;107(2):243-51.
1984: Sokoloff P; Martres M P; Delandre M; Redouane K; Schwartz J C
3H-Dopamine binding sites differ in rat striatum and pituitary.
Naunyn-Schmiedeberg's archives of pharmacology 1984;327(3):221-7.
1983: Chaillet P; Marçais-Collado H; Costentin J; Yi C C; De La Baume S; Schwartz J C
Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
European journal of pharmacology 1983;86(3-4):329-36.
1983: de la Baume S; Yi C C; Schwartz J C; Chaillet P; Marcais-Collado H; Costentin J
Participation of both 'enkephalinase' and aminopeptidase activities in the metabolism of endogenous enkephalins.
Neuroscience 1983;8(1):143-51.
1983: Schwartz J C; de la Baume S; Yi C C; Chaillet P; Marcais-Collado H; Costentin J
Peptidases involved in the inactivation of exogenous and endogenous enkephalins.
Journal of neural transmission. Supplementum 1983;18():235-43.
1983: Schwartz J C; Llorens Cortes C; Rose C; Quach T T; Pollard H
Adaptive changes of neurotransmitter receptor mechanisms in the central nervous system.
Progress in brain research 1983;58():117-29.
1982: de la Baume S; Gros C; Yi C C; Chaillet P; Marcais-Collado H; Costentin J; Schwartz J C
Selective participation of both "enkephalinase" and aminopeptidase activities in the metabolism of endogenous enkephalins.
Life sciences 1982;31(16-17):1753-6.
1982: Schwartz J C; De La Baume S; Yi C C; Chaillet P; Marcais-Collado H; Costentin J
Enkephalin metabolism in brain and its inhibition.
Progress in neuro-psychopharmacology & biological psychiatry 1982;6(4-6):665-71.
1980: Dam Trung Tuong M; Garbarg M; Schwartz J C
Pharmacological specificity of brain histamine H2-receptors differs in intact cells and cell-free preparations.
Nature 1980;287(5782):548-51.
1980: Schwartz J C; Pollard H; Quach T T
Histamine as a neurotransmitter in mammalian brain: neurochemical evidence.
Journal of neurochemistry 1980;35(1):26-33.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jean-Charles Schwartz

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jean-Charles Schwartz (preview)

All Publications